Emily Stone

Dr. Emily Stone


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
JJJames Jett
James Jett
ESEmily Stone
Emily Stone
GWGraham Warren
Graham Warren
KCK Michael Cummings
K Michael Cummings

1 October 2018 in Lung Cancer
Verified
Journal Article
Closed access
ESEmily Stone
Emily Stone
NRNicole Rankin
Nicole Rankin
SKStephen Kerr
Stephen Kerr
KFKwun Fong
Kwun Fong
DCDavid C. Currow
David C. Currow
TSTim Shaw
Tim Shaw

CDCandice Donnelly
Candice Donnelly
AJAnna Janssen
Anna Janssen
SVShalini Vinod
Shalini Vinod
ESEmily Stone
Emily Stone
PHPaul Harnett
Paul Harnett
TSTim Shaw
Tim Shaw
Historically, quality measurement analyses utilize manual chart abstraction from data collected primarily for administrative purposes. These methods are resource-intensive, time-delayed, and often lack clinical relevance. Electronic Medical Records (EMRs) have increased data availability and opportunities for quality measurement. However, little is known about the effectiveness of Measurement Feedback Systems (MFSs) in utilizing EMR data. This study explores the effectiveness and characteristics of EMR-enabled MFSs in tertiary care. The search strategy guided by the PICO Framework was executed in four databases. Two reviewers screened abstracts and manuscripts. Data on effect and intervention characteristics were extracted using a tailored version of the Cochrane EPOC abstraction tool. Due to study heterogeneity, a narrative synthesis was conducted and reported according to PRISMA guidelines. A total of 14 unique MFS studies were extracted and synthesized, of which 12 had positive effects on outcomes. Findings indicate that quality measurement using EMR data is feasible in certain contexts and successful MFSs often incorporated electronic feedback methods, supported by clinical leadership and action planning. EMR-enabled MFSs have the potential to reduce the burden of data collection for quality measurement but further research is needed to evaluate EMR-enabled MFSs to translate and scale findings to broader implementation contexts.

1 December 2017 in Translational Lung Cancer Research
Verified
Journal Article
Closed access
PDF file
ESEmily Stone
Emily Stone
MPMatthew Peters
Matthew Peters
Young low and middle-income country (LMIC) smokers— implications for global tobacco control

26 July 2020 in Respirology
Verified
Journal Article
Open access
PDF file
CMChristine McDonald
Christine McDonald
SJStuart Jones
Stuart Jones
LBLutz Beckert
Lutz Beckert
BBBillie Bonevski
Billie Bonevski
TBTanya Buchanan
Tanya Buchanan
MPMatthew Peters
Matthew Peters
The TSANZ develops position statements where insufficient data exist to write formal clinical guidelines. In 2018, the TSANZ addressed the question of potential benefits and health impacts of electronic cigarettes (EC). The working party included groups focused on health impacts, smoking cessation, youth issues and priority populations. The 2018 report on the Public Health Consequences of E‐Cigarettes from the United States NASEM was accepted as reflective of evidence to mid‐2017. A search for papers subsequently published in peer‐reviewed journals was conducted in August 2018. A small number of robust and important papers published until March 2019 were also identified and included. Groups identified studies that extended, modified or contradicted the NASEM report. A total of 3793 papers were identified and reviewed, with summaries and draft position statements developed and presented to TSANZ membership in April 2019. After feedback from members and external reviewers, a collection of position statements was finalized in December 2019. EC have adverse lung effects and harmful effects of long‐term use are unknown. EC are unsuitable consumer products for recreational use, part‐substitution for smoking or long‐term exclusive use by former smokers. Smokers who require support to quit smoking should be directed towards approved medication in conjunction with behavioural support as having the strongest evidence for efficacy and safety. No specific EC product can be recommended as effective and safe for smoking cessation. Smoking cessation claims in relation to EC should be assessed by established regulators.

11 April 2018 in Respirology
Verified
Journal Article
Open access
PDF file
ESEmily Stone
Emily Stone
NRNicole Rankin
Nicole Rankin
JPJane Louise Phillips
Jane Louise Phillips
KFKwun Fong
Kwun Fong
DCDavid C. Currow
David C. Currow
TSTim Shaw
Tim Shaw
Background and objective: While multidisciplinary team (MDT) care in lung cancer is widely practiced, there are few guidelines for MDT on best data collection strategies. MDT meetings need ready access to information for the provision of optimal treatment recommendations (the primary purpose of the meeting), audit of team performance and benchmarking. This study aimed to develop a practical data set designed for these goals through a recognized consensus process with health professionals who participate in formal MDT settings.Methods: A modified Delphi process with three iterations (two surveys and one consensus conference) was carried out involving over 100 Australian lung cancer MDT health professionals.Results: In total, 122 lung cancer MDT health professionals responded to the Round 1 survey from over 350 invitees. Of the 122, 98 were available for invitation to Round 2. Of 98, 52 (53%) invitees responded to the Round 2 survey. After two rounds, 51 data elements across 8 domains (patient demographics, risk factors, biopsy data, staging, timeliness, treatment, follow‐up and patient selection) achieved consensus, defined as 80% agreement. For Round 3, 33 MDT lead clinicians were invited to participate in a consensus conference. Of 33, 14 (42%) invitees distilled the 47 data elements into 23 elements across 8 domains to address the study objectives.Conclusion: A practical data set for lung cancer MDT to use for optimal treatment recommendations and to evaluate team performance was developed through recognized consensus methodology. Access to streamlined, relevant and feasible data collection strategies may improve MDT decision‐making, audit of team performance and facilitate benchmarking.